HOME >> MEDICINE >> NEWS
Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh

s, acute cellular rejection in the first six months occurred in 38 percent of those who received bone marrow, compared to 82 percent of those who did not. Most of the rejection episodes in the group of bone marrow-augmented patients were mild as compared to moderate to severe in the recipients who did not receive bone marrow. There were no differences in the incidence of chronic rejection for the two groups of heart recipients.

In lung transplant patients, the most significant result was a reduced incidence of chronic rejection, a process that prevents air to pass through the lung's bronchioles. Chronic rejection occurred in 9 percent of the bone marrow patients and in 42 percent of those who did not receive bone marrow. In addition, those lung patients receiving bone marrow had higher measures of donor-specific hyporeactivity. This indicates that the recipient's immune defense is capable of fighting unwanted infections but is less likely to initiate an attack against the donor organ.

In studies to detect chimerism in a small subset of patients a year after transplantation, levels appeared to be higher in those who received bone marrow. The safety of the bone marrow procedure was also a parameter studied. Patients were not pre-treated with irradiation to "make space" for the bone marrow, nor was the bone marrow modified in any way. As a result, the researchers believe the risk of graft vs. host disease (GVHD) was minimized. GVHD, a common complication of bone marrow transplantation, occurs when donor immune cells attack recipient tissues.

"The results in these patients who received the extra boost of donor immune system cells indicate the procedure is safe and augments the cellular environment we believe is necessary for long-term acceptance of a transplanted organ. Chimerism is a prerequisite for but not synonymous with tolerance," Dr. McCurry reported.

The study of combined solid organ and bone marrow transplants is the clinical centerpi
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
24-Apr-1999


Page: 1 2 3

Related medicine news :

1. Marrow injection gets damaged hearts moving
2. Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
3. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
4. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
6. The European Society of Cardiology launches Women at Heart
7. Heart surgeons publish death rates
8. Heart attack treatment gap may be closing for women
9. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
10. Brenner Childrens Hospital named to NIH Pediatric Heart Network
11. Heart patients treated by non-cardiologists less likely to receive medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a ... Miami, and Raleigh regions, is organizing an extended charity drive to benefit the ... chromosome abnormality. , After struggling since birth with several health challenges, T.J. was ...
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
Cached News: